Sterling Biotech Ltd.
has completed restructuring of Foreign Currency Convertible Bonds of USD180 mn
Health is a sector shaped both by global trends, technologies and innovation, and by local market conditions, demographics and regulations.
Investment and consolidation are driven by:
We serve our corporate, financial sponsor and entrepreneurial clients by combining our deep capabilities and insights across the world with our global perspectives and transactional track record. Our experience spans healthcare services, medical technology, pharma and biotech and consumer health.
Sterling Biotech Ltd.
has completed restructuring of Foreign Currency Convertible Bonds of USD180 mn
2013
Debtor Advisor
OPV Pharmaceutical JSC Acquisition of significant stake by
2012
Sellside Advisor